Penisole
Penisole Price range: $ 50,00 through $ 454,00
Back to products
Periactin
Periactin Price range: $ 40,00 through $ 160,00

Pepcid

Price range: $ 70,00 through $ 245,00

Pepcid is a highly effective medication designed to provide fast-acting relief from heartburn associated with acid indigestion and sour stomach. Its active ingredient, famotidine, works by reducing the overall production of acid in the digestive system to alleviate discomfort. This formula is specifically indicated for the prevention and treatment of symptoms brought on by consuming certain foods and beverages. Each dose provides long-lasting support for up to 12 hours, ensuring you stay comfortable throughout the day or night. Pepcid remains a trusted choice for managing occasional acid-related issues and maintaining a healthy, balanced stomach environment.

Active substance: Famotidine
SKU: Pepcid Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Pepcid belongs to a group of medicines called histamine H2-receptor antagonists. It functions by decreasing the volume and acidity of gastric acid production in the stomach. Depending on the strength and specific formulation, it is available over-the-counter for self-care or by prescription for clinical conditions, dispensed in accordance with applicable federal and state regulations.

The active substance, famotidine, competitively blocks H2 receptors located on the parietal cells of the gastric mucosa. This action helps alleviate symptoms associated with excess stomach acid, such as heartburn, acid indigestion, and sour stomach.

Parameter Details
Active ingredient Famotidine
Therapeutic class Histamine H2-receptor antagonist
Dosage form Oral tablets, chewable tablets, powder for oral suspension
Primary purpose Reduction of gastric acid secretion
Route of administration Oral
Storage Store at 68°F to 77°F (20°C to 25°C)

Clinical Overview and Pharmacodynamics

How the drug works

The mechanism of action involves competitive inhibition of histamine at the H2-receptors of gastric parietal cells. By selectively blocking these receptors, the drug inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, betazole, or pentagastrin. In addition to reducing overall gastric acid volume, it decreases pepsin content proportionately. The antisecretory effect is direct and dose-dependent. Unlike some other acid-reducing agents, it does not exert direct anticholinergic or alpha- or beta-adrenergic activity, nor does it significantly alter serum gastrin levels during short-term administration.

Main uses

Indications for use depend on the formulation and clinical setting. Over-the-counter strengths are indicated for the relief and prevention of heartburn, acid indigestion, and sour stomach brought on by consuming acid-inducing foods or beverages. Prescription-strength formulations are indicated for the short-term treatment of active duodenal ulcers, active benign gastric ulcers, and gastroesophageal reflux disease (GERD), including erosive esophagitis. Furthermore, high-dose prescription therapy is utilized for the long-term management of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome.

Administration and Dosage Recommendations

How to take it

Dosing schedule variations depend on the specific condition being managed and whether the therapy is self-administered or prescriber-directed. For self-directed relief or prevention of heartburn, 10 mg or 20 mg is taken orally with a glass of water, either as symptoms occur or 10 to 60 minutes prior to eating food or drinking beverages expected to trigger symptoms. For prescription indications such as active duodenal ulcer treatment, standard clinical protocols often involve 40 mg once daily at bedtime or 20 mg twice daily for 4 to 8 weeks. Maintenance therapy for healed duodenal ulcers is typically 20 mg once daily at bedtime. Adjustments to the dosing schedule are necessary in patients with severe renal impairment to prevent drug accumulation.

Pharmacokinetics and Metabolism

What happens in the body

Following oral administration, famotidine is incompletely absorbed from the gastrointestinal tract, with bioavailability ranging between 40% and 45%. Bioavailability is not clinically significantly altered by the presence of food. Peak plasma concentrations are typically attained within 1 to 3 hours after administration. Plasma protein binding is relatively low, at approximately 15% to 20%. The elimination half-life from plasma ranges from 2.5 to 3.5 hours in adults with normal renal function. Famotidine undergoes minimal hepatic metabolism and is primarily excreted unchanged by the kidneys via glomerular filtration and active tubular secretion, with 25% to 30% of an oral dose recovered in urine.

Safety Profile and Clinical Considerations

Adverse reactions

Adverse reactions associated with famotidine are generally mild and infrequent. The most commonly reported central nervous system side effect is headache, occurring in a small percentage of treated individuals. Dizziness, diarrhea, and constipation have also been documented during clinical evaluations. Rare but more severe adverse reactions include central nervous system effects such as confusion, agitation, hallucinations, and somnolence, which occur predominantly in elderly individuals or patients with compromised kidney function. Hypersensitivity reactions, including anaphylaxis, angioedema, and severe cutaneous adverse reactions, represent rare complications requiring immediate clinical evaluation.

Compatibility with other medicines

Drug interactions with famotidine are less frequent compared to older H2-receptor antagonists because famotidine does not significantly inhibit the cytochrome P450 hepatic enzyme system. However, alterations in gastric pH can impact the bioavailability of concomitant medications that rely on acidic conditions for optimal dissolution and gastrointestinal absorption. For instance, the systemic absorption of ketoconazole, itraconazole, and certain antiretroviral agents like atazanavir or rilpivirine may be reduced when co-administered. Concurrent use with aluminum hydroxide or magnesium hydroxide antacids may slightly reduce famotidine absorption; therefore, administration should be appropriately timed if combined.

Drug Interactions and Precautions

Important precautions

Prior to initiating treatment, underlying malignant gastric disease should be ruled out, as symptomatic response to therapy does not preclude the presence of gastric neoplasm. Patients with moderate to severe renal insufficiency require careful monitoring and appropriate dose reduction or interval extension to account for prolonged drug elimination. Caution is advised when administering high doses to elderly individuals due to an elevated risk of central nervous system side effects. Over-the-counter use should not exceed 14 consecutive days unless directed by a qualified healthcare professional.

Food and alcohol interactions

Food does not significantly impede the absorption of famotidine, allowing the medication to be taken with or without meals. However, individuals suffering from acid-related symptoms are advised to avoid known dietary triggers, such as highly acidic, greasy, spicy, or fried foods. Alcohol consumption can directly irritate the gastric mucosa and exacerbate symptoms of acid reflux or peptic ulcer disease. Although famotidine does not interfere with alcohol metabolism, combining acid reducers with alcohol consumption may obscure ongoing mucosal damage or delay symptomatic recovery.

Special populations

In pregnant women, famotidine should be used during pregnancy only if clearly needed, as adequate, well-controlled studies in pregnant individuals are limited. Famotidine is excreted into human milk; thus, nursing mothers should weigh potential benefits against risks or consult a provider before use. Pediatric safety and effectiveness have been established for specific prescription indications in infants and children, though dosing must be carefully calculated based on body weight. Elderly patients often present with age-related decreases in renal function, necessitating careful monitoring of renal status and potential dose modifications.

If you skip a dose

If a scheduled dose is missed during a prescribed regimen, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, resuming the regular dosing schedule. Patients should never double the dose to compensate for a missed administration.

Storage and expiration

Famotidine tablets and chewable formulations should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with temporary excursions permitted between 59°F and 86°F (15°C to 30°C). The medication must be kept in a dry place, protected from excessive moisture, heat, and direct light. Reconstituted oral suspensions typically require specific storage conditions, such as refrigeration, and must be discarded after the designated expiration period, usually within 30 days.

Frequently Asked Questions

Q: How quickly does famotidine begin reducing stomach acid?

A: Famotidine generally begins to inhibit gastric acid production within 1 hour after oral administration. Peak acid suppression is typically observed within 1 to 3 hours, providing symptomatic relief that can persist for up to 10 to 12 hours depending on the administered dose.

Q: Can Pepcid be taken daily on a long-term basis without medical supervision?

A: Over-the-counter formulations of Pepcid are intended for short-term use up to 14 days. Daily administration beyond 14 consecutive days requires comprehensive medical evaluation to investigate underlying causes of persistent acid production and rule out serious gastrointestinal conditions.

Q: What should be done if stomach symptoms persist after two weeks of use?

A: If acid reflux, heartburn, or abdominal discomfort continues after 14 days of self-treatment, administration should be stopped and a medical provider consulted. Persistent symptoms may indicate conditions such as severe GERD, erosive esophagitis, or peptic ulcer disease requiring prescription-strength interventions.

Q: Does Pepcid affect the absorption of other oral medications?

A: By reducing stomach acidity, Pepcid can decrease the absorption of medications requiring an acidic environment, such as azole antifungals and certain antiretroviral agents. Patients taking concurrent chronic therapy should review potential absorption interactions with a pharmacist or physician.

Q: Is it safe to consume alcohol while managing acid reflux with Pepcid?

A: While famotidine does not pharmacologically interact with alcohol, drinking alcohol can irritate the gastric lining and trigger acid secretion. Patients using acid reducers are generally advised to limit or avoid alcohol to achieve optimal symptom management.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

20mg

,

40mg

Package

56 pills

,

84 pills

,

112 pills

,

168 pills

,

224 pills

,

336 pills

Ενεργός Ουσία